Ingrid E. Wertz

11.5k total citations · 3 hit papers
42 papers, 6.5k citations indexed

About

Ingrid E. Wertz is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ingrid E. Wertz has authored 42 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Ingrid E. Wertz's work include Ubiquitin and proteasome pathways (27 papers), Protein Degradation and Inhibitors (11 papers) and NF-κB Signaling Pathways (11 papers). Ingrid E. Wertz is often cited by papers focused on Ubiquitin and proteasome pathways (27 papers), Protein Degradation and Inhibitors (11 papers) and NF-κB Signaling Pathways (11 papers). Ingrid E. Wertz collaborates with scholars based in United States, France and Germany. Ingrid E. Wertz's co-authors include Vishva M. Dixit, Karen O’Rourke, Honglin Zhou, Michael Eby, Somasekar Seshagiri, Domagoj Vucic, S.G. Hymowitz, David Arnott, Rohan T. Baker and Christian Wiesmann and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Ingrid E. Wertz

42 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling

2004 1.5k citations Ingrid E. Wertz, Karen O’Rourke et al. Nature profile →
The ubiquitin ligase COP1 is a critical negative regulator of p53

2004 568 citations David Dornan, Ingrid E. Wertz et al. Nature profile →
Ubiquitination in the regulation of inflammatory cell death and cancer

2021 322 citations Ingrid E. Wertz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ingrid E. Wertz United States	31	4.7k	2.0k	2.0k	1.8k	648	42	6.5k
Manuel S. Rodríguez Spain	36	5.9k 1.2×	1.5k 0.7×	1.4k 0.7×	2.2k 1.2×	751 1.2×	104	7.1k
Steven C. Ley United Kingdom	45	3.9k 0.8×	4.0k 2.0×	1.8k 0.9×	1.4k 0.8×	475 0.7×	83	8.1k
Honglin Zhou China	25	3.5k 0.7×	1.8k 0.9×	1.5k 0.7×	779 0.4×	832 1.3×	51	5.8k
Frank Kischkel Germany	15	6.1k 1.3×	3.1k 1.5×	1.6k 0.8×	1.5k 0.8×	941 1.5×	19	7.7k
Keun Il Kim South Korea	41	3.1k 0.7×	1.9k 0.9×	800 0.4×	1.2k 0.7×	836 1.3×	86	5.2k
Jamie I. Fletcher Australia	28	5.1k 1.1×	1.0k 0.5×	912 0.5×	2.0k 1.1×	544 0.8×	63	7.1k
Dhananjaya V. Kalvakolanu United States	44	3.1k 0.7×	2.0k 1.0×	813 0.4×	1.7k 0.9×	620 1.0×	114	5.5k
Louise Carlson United States	35	3.0k 0.6×	2.8k 1.4×	2.0k 1.0×	1.5k 0.8×	484 0.7×	60	5.9k
Jürg Tschopp Switzerland	41	5.7k 1.2×	3.3k 1.6×	1.5k 0.7×	1.5k 0.8×	1.0k 1.6×	50	7.7k
Vito J. Palombella United States	28	6.9k 1.4×	2.4k 1.2×	2.4k 1.2×	2.9k 1.6×	789 1.2×	57	10.0k

Countries citing papers authored by Ingrid E. Wertz

Since Specialization

Citations

This map shows the geographic impact of Ingrid E. Wertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid E. Wertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid E. Wertz more than expected).

Fields of papers citing papers by Ingrid E. Wertz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid E. Wertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid E. Wertz. The network helps show where Ingrid E. Wertz may publish in the future.

Co-authorship network of co-authors of Ingrid E. Wertz

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid E. Wertz. A scholar is included among the top collaborators of Ingrid E. Wertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid E. Wertz. Ingrid E. Wertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Oscar W., et al.. (2024). Exploiting the Cullin E3 Ligase Adaptor Protein SKP1 for Targeted Protein Degradation. ACS Chemical Biology. 19(2). 442–450. 20 indexed citations

Watson, Edmond R., Scott J. Novick, Mary E. Matyskiela, et al.. (2022). Molecular glue CELMoD compounds are regulators of cereblon conformation. Science. 378(6619). 549–553. 94 indexed citations

Davies, C., Simon E. Vidal, Lilian Phu, et al.. (2021). Antibody toolkit reveals N-terminally ubiquitinated substrates of UBE2W. Nature Communications. 12(1). 4608–4608. 17 indexed citations

Reichermeier, Kurt M., Ronny Straube, Justin M. Reitsma, et al.. (2020). PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network. Molecular Cell. 77(5). 1092–1106.e9. 55 indexed citations

Hewings, David S., Johanna Heideker, P. Taylur, et al.. (2018). Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. Nature Communications. 9(1). 1162–1162. 71 indexed citations

Wertz, Ingrid E. & Xiao‐Jing Wang. (2018). From Discovery to Bedside: Targeting the Ubiquitin System. Cell chemical biology. 26(2). 156–177. 116 indexed citations

Hewings, David S., John A. Flygare, Matthew Bogyo, & Ingrid E. Wertz. (2017). Activity‐based probes for the ubiquitin conjugation–deconjugation machinery: new chemistries, new tools, and new insights. FEBS Journal. 284(10). 1555–1576. 94 indexed citations

Lello, Paola Di, Richard Pastor, Jeremy Murray, et al.. (2017). Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques. Journal of Medicinal Chemistry. 60(24). 10056–10070. 65 indexed citations

Tran, Hoanh, Daisy Bustos, Ronald Yeh, et al.. (2013). HectD1 E3 Ligase Modifies Adenomatous Polyposis Coli (APC) with Polyubiquitin to Promote the APC-Axin Interaction. Journal of Biological Chemistry. 288(6). 3753–3767. 51 indexed citations

10.

Vitari, Alberto C., Kevin G. Leong, Kim Newton, et al.. (2011). COP1 is a tumour suppressor that causes degradation of ETS transcription factors. Nature. 474(7351). 403–406. 138 indexed citations

11.

Bosanac, Ivan, Ingrid E. Wertz, Borlan Pan, et al.. (2010). Ubiquitin Binding to A20 ZnF4 Is Required for Modulation of NF-κB Signaling. Molecular Cell. 40(4). 548–557. 154 indexed citations

12.

Hymowitz, S.G. & Ingrid E. Wertz. (2010). A20: from ubiquitin editing to tumour suppression. Nature reviews. Cancer. 10(5). 332–341. 205 indexed citations

13.

Wertz, Ingrid E. & Vishva M. Dixit. (2008). Ubiquitin-mediated regulation of TNFR1 signaling. Cytokine & Growth Factor Reviews. 19(3-4). 313–324. 75 indexed citations

14.

Newton, Kim, M Matsumoto, Ingrid E. Wertz, et al.. (2008). Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies. Cell. 134(4). 668–678. 473 indexed citations

15.

Mollah, Sahana, Ingrid E. Wertz, Qui Phung, et al.. (2007). Targeted mass spectrometric strategy for global mapping of ubiquitination on proteins. Rapid Communications in Mass Spectrometry. 21(20). 3357–3364. 45 indexed citations

16.

Zhou, Honglin, Denise M. Monack, Nobuhiko Kayagaki, et al.. (2005). Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κB activation. The Journal of Experimental Medicine. 202(10). 1327–1332. 187 indexed citations

17.

Wertz, Ingrid E., Karen O’Rourke, Zemin Zhang, et al.. (2004). Human De-Etiolated-1 Regulates c-Jun by Assembling a CUL4A Ubiquitin Ligase. Science. 303(5662). 1371–1374. 301 indexed citations

18.

Dornan, David, Ingrid E. Wertz, Harumi Shimizu, et al.. (2004). The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature. 429(6987). 86–92. 568 indexed citations breakdown →

19.

Wertz, Ingrid E. & Vishva M. Dixit. (2000). Characterization of Calcium Release-activated Apoptosis of LNCaP Prostate Cancer Cells. Journal of Biological Chemistry. 275(15). 11470–11477. 110 indexed citations

20.

Wertz, Ingrid E., Arline D. Deitch, Paul H. Gumerlock, et al.. (1996). Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissues. Human Pathology. 27(6). 573–580. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact